APO Research
Talk to an analyst

APO RESEARCH · REPORT

Poloxamer 338

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Poloxamer 338 Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchPoloxamer 338 Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Poloxamer 338 Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Poloxamer 338 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Poloxamer 338 Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Poloxamer 338 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Poloxamer 338 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Poloxamer 338's global sales reached XX (Tons) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned BASF as the global sales leader, a title it has maintained for several consecutive years. Notably, BASF's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Tons), a change of XX% from the previous year. In Europe, sales were XX (Tons), showing a year-on-year of XX%. In the US, sales were XX (Tons), a year-on-year change of XX%.

The major global manufacturers in the Poloxamer 338 market include BASF, Croda, Comercial Química Massó and CD Formulation, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Poloxamer 338 production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Poloxamer 338 by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Poloxamer 338, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Poloxamer 338, also provides the consumption of main regions and countries. Of the upcoming market potential for Poloxamer 338, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Poloxamer 338 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Poloxamer 338 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Poloxamer 338 sales, projected growth trends, production technology, application and end-user industry.

Poloxamer 338 Segment by Company

BASF

Croda

Comercial Química Massó

CD Formulation

Poloxamer 338 Segment by Type

Purity 99%

Purity 99.9%

Others

Poloxamer 338 Segment by Application

Cosmetic

Pharmaceuticals

Others

Poloxamer 338 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poloxamer 338 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Poloxamer 338 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poloxamer 338.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Poloxamer 338 production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Poloxamer 338 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Poloxamer 338 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Poloxamer 338 sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Poloxamer 338 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Purity 99% Major Manufacturers Table 3. Purity 99.9% Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Poloxamer 338 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cosmetic Major Manufacturers Table 7. Pharmaceuticals Major Manufacturers Table 8. Others Major Manufacturers Table 9. Poloxamer 338 Industry Trends Table 10. Poloxamer 338 Industry Drivers Table 11. Poloxamer 338 Industry Opportunities and Challenges Table 12. Poloxamer 338 Industry Restraints Table 13. Global Poloxamer 338 Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 14. Global Poloxamer 338 Production by Region (2021-2026) & (Tons) Table 15. Global Poloxamer 338 Production by Region (2027-2032) & (Tons) Table 16. Global Poloxamer 338 Production Market Share by Region (2021-2026) Table 17. Global Poloxamer 338 Production Market Share by Region (2027-2032) Table 18. Global Poloxamer 338 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Poloxamer 338 Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Poloxamer 338 Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Poloxamer 338 Revenue Market Share by Region (2021-2026) Table 22. Global Poloxamer 338 Revenue Market Share by Region (2027-2032) Table 23. Global Poloxamer 338 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 24. Global Poloxamer 338 Sales by Region (2021-2026) & (Tons) Table 25. Global Poloxamer 338 Sales by Region (2027-2032) & (Tons) Table 26. Global Poloxamer 338 Sales Market Share by Region (2021-2026) Table 27. Global Poloxamer 338 Sales Market Share by Region (2027-2032) Table 28. Global Poloxamer 338 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Poloxamer 338 Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Poloxamer 338 Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Poloxamer 338 Sales Market Share by Manufacturers (2021-2026) Table 32. Global Poloxamer 338 Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 33. Global Poloxamer 338 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Poloxamer 338 Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Poloxamer 338 Manufacturers, Product Type & Application Table 36. Global Poloxamer 338 Manufacturers Commercialization Time Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Poloxamer 338 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 39. Global Poloxamer 338 Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Poloxamer 338 Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Poloxamer 338 Revenue Market Share by Type (2021-2026) Table 42. Global Poloxamer 338 Revenue Market Share by Type (2027-2032) Table 43. Global Poloxamer 338 Sales by Type (2021-2026) & (Tons) Table 44. Global Poloxamer 338 Sales by Type (2027-2032) & (Tons) Table 45. Global Poloxamer 338 Sales Market Share by Type (2021-2026) Table 46. Global Poloxamer 338 Sales Market Share by Type (2027-2032) Table 47. Global Poloxamer 338 Price by Type (2021-2026) & (US$/Ton) Table 48. Global Poloxamer 338 Price by Type (2027-2032) & (US$/Ton) Table 49. Global Poloxamer 338 Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Poloxamer 338 Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Poloxamer 338 Revenue Market Share by Application (2021-2026) Table 52. Global Poloxamer 338 Revenue Market Share by Application (2027-2032) Table 53. Global Poloxamer 338 Sales by Application (2021-2026) & (Tons) Table 54. Global Poloxamer 338 Sales by Application (2027-2032) & (Tons) Table 55. Global Poloxamer 338 Sales Market Share by Application (2021-2026) Table 56. Global Poloxamer 338 Sales Market Share by Application (2027-2032) Table 57. Global Poloxamer 338 Price by Application (2021-2026) & (US$/Ton) Table 58. Global Poloxamer 338 Price by Application (2027-2032) & (US$/Ton) Table 59. BASF Company Information Table 60. BASF Business Overview Table 61. BASF Poloxamer 338 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 62. BASF Poloxamer 338 Product Portfolio Table 63. BASF Recent Development Table 64. Croda Company Information Table 65. Croda Business Overview Table 66. Croda Poloxamer 338 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 67. Croda Poloxamer 338 Product Portfolio Table 68. Croda Recent Development Table 69. Comercial Química Massó Company Information Table 70. Comercial Química Massó Business Overview Table 71. Comercial Química Massó Poloxamer 338 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. Comercial Química Massó Poloxamer 338 Product Portfolio Table 73. Comercial Química Massó Recent Development Table 74. CD Formulation Company Information Table 75. CD Formulation Business Overview Table 76. CD Formulation Poloxamer 338 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. CD Formulation Poloxamer 338 Product Portfolio Table 78. CD Formulation Recent Development Table 79. North America Poloxamer 338 Revenue by Type (2021-2026) & (US$ Million) Table 80. North America Poloxamer 338 Revenue by Type (2027-2032) & (US$ Million) Table 81. North America Poloxamer 338 Sales by Type (2021-2026) & (Tons) Table 82. North America Poloxamer 338 Sales by Type (2027-2032) & (Tons) Table 83. North America Poloxamer 338 Sales Price by Type (2021-2026) & (US$/Ton) Table 84. North America Poloxamer 338 Sales Price by Type (2027-2032) & (US$/Ton) Table 85. North America Poloxamer 338 Revenue by Application (2021-2026) & (US$ Million) Table 86. North America Poloxamer 338 Revenue by Application (2027-2032) & (US$ Million) Table 87. North America Poloxamer 338 Sales by Application (2021-2026) & (Tons) Table 88. North America Poloxamer 338 Sales by Application (2027-2032) & (Tons) Table 89. North America Poloxamer 338 Sales Price by Application (2021-2026) & (US$/Ton) Table 90. North America Poloxamer 338 Sales Price by Application (2027-2032) & (US$/Ton) Table 91. North America Poloxamer 338 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Poloxamer 338 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 93. North America Poloxamer 338 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 94. North America Poloxamer 338 Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 95. North America Poloxamer 338 Sales by Country (2021-2026) & (Tons) Table 96. North America Poloxamer 338 Sales by Country (2027-2032) & (Tons) Table 97. North America Poloxamer 338 Sales Price by Country (2021-2026) & (US$/Ton) Table 98. North America Poloxamer 338 Sales Price by Country (2027-2032) & (US$/Ton) Table 99. United States Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 100. Canada Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 101. Mexico Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 102. Europe Poloxamer 338 Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Poloxamer 338 Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Poloxamer 338 Sales by Type (2021-2026) & (Tons) Table 105. Europe Poloxamer 338 Sales by Type (2027-2032) & (Tons) Table 106. Europe Poloxamer 338 Sales Price by Type (2021-2026) & (US$/Ton) Table 107. Europe Poloxamer 338 Sales Price by Type (2027-2032) & (US$/Ton) Table 108. Europe Poloxamer 338 Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe Poloxamer 338 Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe Poloxamer 338 Sales by Application (2021-2026) & (Tons) Table 111. Europe Poloxamer 338 Sales by Application (2027-2032) & (Tons) Table 112. Europe Poloxamer 338 Sales Price by Application (2021-2026) & (US$/Ton) Table 113. Europe Poloxamer 338 Sales Price by Application (2027-2032) & (US$/Ton) Table 114. Europe Poloxamer 338 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe Poloxamer 338 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. Europe Poloxamer 338 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. Europe Poloxamer 338 Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 118. Europe Poloxamer 338 Sales by Country (2021-2026) & (Tons) Table 119. Europe Poloxamer 338 Sales by Country (2027-2032) & (Tons) Table 120. Europe Poloxamer 338 Sales Price by Country (2021-2026) & (US$/Ton) Table 121. Europe Poloxamer 338 Sales Price by Country (2027-2032) & (US$/Ton) Table 122. Germany Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 123. France Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 124. U.K. Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 125. Italy Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 126. Russia Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 127. Spain Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 128. Netherlands Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 129. Switzerland Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 130. Sweden Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 131. Poland Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 132. China Poloxamer 338 Revenue by Type (2021-2026) & (US$ Million) Table 133. China Poloxamer 338 Revenue by Type (2027-2032) & (US$ Million) Table 134. China Poloxamer 338 Sales by Type (2021-2026) & (Tons) Table 135. China Poloxamer 338 Sales by Type (2027-2032) & (Tons) Table 136. China Poloxamer 338 Sales Price by Type (2021-2026) & (US$/Ton) Table 137. China Poloxamer 338 Sales Price by Type (2027-2032) & (US$/Ton) Table 138. China Poloxamer 338 Revenue by Application (2021-2026) & (US$ Million) Table 139. China Poloxamer 338 Revenue by Application (2027-2032) & (US$ Million) Table 140. China Poloxamer 338 Sales by Application (2021-2026) & (Tons) Table 141. China Poloxamer 338 Sales by Application (2027-2032) & (Tons) Table 142. China Poloxamer 338 Sales Price by Application (2021-2026) & (US$/Ton) Table 143. China Poloxamer 338 Sales Price by Application (2027-2032) & (US$/Ton) Table 144. Asia Poloxamer 338 Revenue by Type (2021-2026) & (US$ Million) Table 145. Asia Poloxamer 338 Revenue by Type (2027-2032) & (US$ Million) Table 146. Asia Poloxamer 338 Sales by Type (2021-2026) & (Tons) Table 147. Asia Poloxamer 338 Sales by Type (2027-2032) & (Tons) Table 148. Asia Poloxamer 338 Sales Price by Type (2021-2026) & (US$/Ton) Table 149. Asia Poloxamer 338 Sales Price by Type (2027-2032) & (US$/Ton) Table 150. Asia Poloxamer 338 Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia Poloxamer 338 Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Poloxamer 338 Sales by Application (2021-2026) & (Tons) Table 153. Asia Poloxamer 338 Sales by Application (2027-2032) & (Tons) Table 154. Asia Poloxamer 338 Sales Price by Application (2021-2026) & (US$/Ton) Table 155. Asia Poloxamer 338 Sales Price by Application (2027-2032) & (US$/Ton) Table 156. Asia Poloxamer 338 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Asia Poloxamer 338 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Asia Poloxamer 338 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Asia Poloxamer 338 Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 160. Asia Poloxamer 338 Sales by Country (2021-2026) & (Tons) Table 161. Asia Poloxamer 338 Sales by Country (2027-2032) & (Tons) Table 162. Asia Poloxamer 338 Sales Price by Country (2021-2026) & (US$/Ton) Table 163. Asia Poloxamer 338 Sales Price by Country (2027-2032) & (US$/Ton) Table 164. Japan Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 165. South Korea Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 166. India Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 167. Australia Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 168. Taiwan Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 169. Southeast Asia Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 170. SAMEA Poloxamer 338 Revenue by Type (2021-2026) & (US$ Million) Table 171. SAMEA Poloxamer 338 Revenue by Type (2027-2032) & (US$ Million) Table 172. SAMEA Poloxamer 338 Sales by Type (2021-2026) & (Tons) Table 173. SAMEA Poloxamer 338 Sales by Type (2027-2032) & (Tons) Table 174. SAMEA Poloxamer 338 Sales Price by Type (2021-2026) & (US$/Ton) Table 175. SAMEA Poloxamer 338 Sales Price by Type (2027-2032) & (US$/Ton) Table 176. SAMEA Poloxamer 338 Revenue by Application (2021-2026) & (US$ Million) Table 177. SAMEA Poloxamer 338 Revenue by Application (2027-2032) & (US$ Million) Table 178. SAMEA Poloxamer 338 Sales by Application (2021-2026) & (Tons) Table 179. SAMEA Poloxamer 338 Sales by Application (2027-2032) & (Tons) Table 180. SAMEA Poloxamer 338 Sales Price by Application (2021-2026) & (US$/Ton) Table 181. SAMEA Poloxamer 338 Sales Price by Application (2027-2032) & (US$/Ton) Table 182. SAMEA Poloxamer 338 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. SAMEA Poloxamer 338 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. SAMEA Poloxamer 338 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. SAMEA Poloxamer 338 Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 186. SAMEA Poloxamer 338 Sales by Country (2021-2026) & (Tons) Table 187. SAMEA Poloxamer 338 Sales by Country (2027-2032) & (Tons) Table 188. SAMEA Poloxamer 338 Sales Price by Country (2021-2026) & (US$/Ton) Table 189. SAMEA Poloxamer 338 Sales Price by Country (2027-2032) & (US$/Ton) Table 190. Brazil Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 191. Argentina Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 192. Chile Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 193. Colombia Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 194. Peru Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 195. Saudi Arabia Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 196. Israel Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 197. UAE Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 198. Turkey Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 199. Iran Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 200. Egypt Poloxamer 338 Revenue (2021-2032) & (US$ Million) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Poloxamer 338 Distributors List Table 204. Poloxamer 338 Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Poloxamer 338 Product Image Figure 2. Global Poloxamer 338 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Poloxamer 338 Market Size Share 2021 VS 2025 VS 2032 Figure . Purity 99% Image Figure 1. Purity 99.9% Image Figure 2. Others Image Figure 3. Global Poloxamer 338 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Poloxamer 338 Market Size Share 2021 VS 2025 VS 2032 Figure 5. Cosmetic Image Figure 6. Pharmaceuticals Image Figure 7. Others Image Figure 8. Global Poloxamer 338 Capacity, Capacity Utilization (2021-2032) & (Tons) Figure 9. Global Poloxamer 338 Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 10. Global Poloxamer 338 Production Market Share by Region: 2025 Versus 2032 Figure 11. Global Poloxamer 338 Production Market Share by Region (2021-2032) Figure 12. North America Poloxamer 338 Production Growth Rate (2021-2032) & (Tons) Figure 13. Europe Poloxamer 338 Production Growth Rate (2021-2032) & (Tons) Figure 14. China Poloxamer 338 Production Growth Rate (2021-2032) & (Tons) Figure 15. Japan Poloxamer 338 Production Growth Rate (2021-2032) & (Tons) Figure 16. Global Poloxamer 338 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Poloxamer 338 Revenue (2021-2032) & (US$ Million) Figure 18. Global Poloxamer 338 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Poloxamer 338 Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Poloxamer 338 Revenue Market Share by Region (2021-2032) Figure 21. Global Poloxamer 338 Sales (2021-2032) & (Tons) Figure 22. Global Poloxamer 338 Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 23. Global Poloxamer 338 Sales Market Share by Region (2021-2032) Figure 24. North America Poloxamer 338 Sales YoY (2021-2032) & (Tons) Figure 25. Europe Poloxamer 338 Sales YoY (2021-2032) & (Tons) Figure 26. China Poloxamer 338 Sales YoY (2021-2032) & (Tons) Figure 27. Asia (Excluding China) Poloxamer 338 Sales YoY (2021-2032) & (Tons) Figure 28. South America, Middle East and Africa Poloxamer 338 Sales YoY (2021-2032) & (Tons) Figure 29. Global Poloxamer 338 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Poloxamer 338 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Poloxamer 338 Revenue Market Share by Type (2021-2032) Figure 33. Global Poloxamer 338 Sales Market Share by Type (2021-2032) Figure 34. Global Poloxamer 338 Revenue Market Share by Application (2021-2032) Figure 35. Global Poloxamer 338 Sales Market Share by Application (2021-2032) Figure 36. North America Poloxamer 338 Revenue Share by Type (2021-2032) Figure 37. North America Poloxamer 338 Sales Share by Type (2021-2032) Figure 38. North America Poloxamer 338 Revenue Share by Application (2021-2032) Figure 39. North America Poloxamer 338 Sales Share by Application (2021-2032) Figure 40. North America Poloxamer 338 Revenue Share by Country (2021-2032) Figure 41. North America Poloxamer 338 Sales Share by Country (2021-2032) Figure 42. Europe Poloxamer 338 Revenue Share by Type (2021-2032) Figure 43. Europe Poloxamer 338 Sales Share by Type (2021-2032) Figure 44. Europe Poloxamer 338 Revenue Share by Application (2021-2032) Figure 45. Europe Poloxamer 338 Sales Share by Application (2021-2032) Figure 46. Europe Poloxamer 338 Revenue Share by Country (2021-2032) Figure 47. Europe Poloxamer 338 Sales Share by Country (2021-2032) Figure 48. China Poloxamer 338 Revenue Share by Type (2021-2032) Figure 49. China Poloxamer 338 Sales Share by Type (2021-2032) Figure 50. China Poloxamer 338 Revenue Share by Application (2021-2032) Figure 51. China Poloxamer 338 Sales Share by Application (2021-2032) Figure 52. Asia Poloxamer 338 Revenue Share by Type (2021-2032) Figure 53. Asia Poloxamer 338 Sales Share by Type (2021-2032) Figure 54. Asia Poloxamer 338 Revenue Share by Application (2021-2032) Figure 55. Asia Poloxamer 338 Sales Share by Application (2021-2032) Figure 56. Asia Poloxamer 338 Revenue Share by Country (2021-2032) Figure 57. Asia Poloxamer 338 Sales Share by Country (2021-2032) Figure 58. SAMEA Poloxamer 338 Revenue Share by Type (2021-2032) Figure 59. SAMEA Poloxamer 338 Sales Share by Type (2021-2032) Figure 60. SAMEA Poloxamer 338 Revenue Share by Application (2021-2032) Figure 61. SAMEA Poloxamer 338 Sales Share by Application (2021-2032) Figure 62. SAMEA Poloxamer 338 Revenue Share by Country (2021-2032) Figure 63. SAMEA Poloxamer 338 Sales Share by Country (2021-2032) Figure 64. Poloxamer 338 Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Poloxamer 338 Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 99%
  • Purity 99.9%
  • Others
Applications
  • Cosmetic
  • Pharmaceuticals
  • Others
Companies covered
  • BASF
  • Croda
  • Comercial Química Massó
  • CD Formulation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Poloxamer 338 Market by Type
  3. 1.2.1 Global Poloxamer 338 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Purity 99%
  5. 1.2.3 Purity 99.9%
  6. 1.2.4 Others
  7. 1.3 Poloxamer 338 Market by Application
  8. 1.3.1 Global Poloxamer 338 Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cosmetic
  10. 1.3.3 Pharmaceuticals
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Poloxamer 338 Market Dynamics
  1. 2.1 Poloxamer 338 Industry Trends
  2. 2.2 Poloxamer 338 Industry Drivers
  3. 2.3 Poloxamer 338 Industry Opportunities and Challenges
  4. 2.4 Poloxamer 338 Industry Restraints
3 Global Poloxamer 338 Production Overview
  1. 3.1 Global Poloxamer 338 Production Capacity (2021-2032)
  2. 3.2 Global Poloxamer 338 Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Poloxamer 338 Production by Region
  4. 3.3.1 Global Poloxamer 338 Production by Region (2021-2026)
  5. 3.3.2 Global Poloxamer 338 Production by Region (2027-2032)
  6. 3.3.3 Global Poloxamer 338 Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Poloxamer 338 Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Poloxamer 338 Revenue by Region
  3. 4.2.1 Global Poloxamer 338 Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Poloxamer 338 Revenue by Region (2021-2026)
  5. 4.2.3 Global Poloxamer 338 Revenue by Region (2027-2032)
  6. 4.2.4 Global Poloxamer 338 Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Poloxamer 338 Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Poloxamer 338 Sales by Region
  9. 4.4.1 Global Poloxamer 338 Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Poloxamer 338 Sales by Region (2021-2026)
  11. 4.4.3 Global Poloxamer 338 Sales by Region (2027-2032)
  12. 4.4.4 Global Poloxamer 338 Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Poloxamer 338 Revenue by Manufacturers
  2. 5.1.1 Global Poloxamer 338 Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Poloxamer 338 Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Poloxamer 338 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Poloxamer 338 Sales by Manufacturers
  6. 5.2.1 Global Poloxamer 338 Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Poloxamer 338 Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Poloxamer 338 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Poloxamer 338 Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Poloxamer 338 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Poloxamer 338 Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Poloxamer 338 Manufacturers, Product Type & Application
  13. 5.7 Global Poloxamer 338 Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Poloxamer 338 Market CR5 and HHI
  16. 5.8.2 2025 Poloxamer 338 Tier 1, Tier 2, and Tier 3
6 Poloxamer 338 Market by Type
  1. 6.1 Global Poloxamer 338 Revenue by Type
  2. 6.1.1 Global Poloxamer 338 Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Poloxamer 338 Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Poloxamer 338 Sales by Type
  5. 6.2.1 Global Poloxamer 338 Sales by Type (2021-2032) & (Tons)
  6. 6.2.2 Global Poloxamer 338 Sales Market Share by Type (2021-2032)
  7. 6.3 Global Poloxamer 338 Price by Type
7 Poloxamer 338 Market by Application
  1. 7.1 Global Poloxamer 338 Revenue by Application
  2. 7.1.1 Global Poloxamer 338 Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Poloxamer 338 Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Poloxamer 338 Sales by Application
  5. 7.2.1 Global Poloxamer 338 Sales by Application (2021-2032) & (Tons)
  6. 7.2.2 Global Poloxamer 338 Sales Market Share by Application (2021-2032)
  7. 7.3 Global Poloxamer 338 Price by Application
8 Company Profiles
  1. 8.1 BASF
  2. 8.1.1 BASF Company Information
  3. 8.1.2 BASF Business Overview
  4. 8.1.3 BASF Poloxamer 338 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 BASF Poloxamer 338 Product Portfolio
  6. 8.1.5 BASF Recent Developments
  7. 8.2 Croda
  8. 8.2.1 Croda Company Information
  9. 8.2.2 Croda Business Overview
  10. 8.2.3 Croda Poloxamer 338 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Croda Poloxamer 338 Product Portfolio
  12. 8.2.5 Croda Recent Developments
  13. 8.3 Comercial Química Massó
  14. 8.3.1 Comercial Química Massó Company Information
  15. 8.3.2 Comercial Química Massó Business Overview
  16. 8.3.3 Comercial Química Massó Poloxamer 338 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Comercial Química Massó Poloxamer 338 Product Portfolio
  18. 8.3.5 Comercial Química Massó Recent Developments
  19. 8.4 CD Formulation
  20. 8.4.1 CD Formulation Company Information
  21. 8.4.2 CD Formulation Business Overview
  22. 8.4.3 CD Formulation Poloxamer 338 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 CD Formulation Poloxamer 338 Product Portfolio
  24. 8.4.5 CD Formulation Recent Developments
9 North America
  1. 9.1 North America Poloxamer 338 Market Size by Type
  2. 9.1.1 North America Poloxamer 338 Revenue by Type (2021-2032)
  3. 9.1.2 North America Poloxamer 338 Sales by Type (2021-2032)
  4. 9.1.3 North America Poloxamer 338 Price by Type (2021-2032)
  5. 9.2 North America Poloxamer 338 Market Size by Application
  6. 9.2.1 North America Poloxamer 338 Revenue by Application (2021-2032)
  7. 9.2.2 North America Poloxamer 338 Sales by Application (2021-2032)
  8. 9.2.3 North America Poloxamer 338 Price by Application (2021-2032)
  9. 9.3 North America Poloxamer 338 Market Size by Country
  10. 9.3.1 North America Poloxamer 338 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Poloxamer 338 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Poloxamer 338 Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Poloxamer 338 Market Size by Type
  2. 10.1.1 Europe Poloxamer 338 Revenue by Type (2021-2032)
  3. 10.1.2 Europe Poloxamer 338 Sales by Type (2021-2032)
  4. 10.1.3 Europe Poloxamer 338 Price by Type (2021-2032)
  5. 10.2 Europe Poloxamer 338 Market Size by Application
  6. 10.2.1 Europe Poloxamer 338 Revenue by Application (2021-2032)
  7. 10.2.2 Europe Poloxamer 338 Sales by Application (2021-2032)
  8. 10.2.3 Europe Poloxamer 338 Price by Application (2021-2032)
  9. 10.3 Europe Poloxamer 338 Market Size by Country
  10. 10.3.1 Europe Poloxamer 338 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Poloxamer 338 Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Poloxamer 338 Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Poloxamer 338 Market Size by Type
  2. 11.1.1 China Poloxamer 338 Revenue by Type (2021-2032)
  3. 11.1.2 China Poloxamer 338 Sales by Type (2021-2032)
  4. 11.1.3 China Poloxamer 338 Price by Type (2021-2032)
  5. 11.2 China Poloxamer 338 Market Size by Application
  6. 11.2.1 China Poloxamer 338 Revenue by Application (2021-2032)
  7. 11.2.2 China Poloxamer 338 Sales by Application (2021-2032)
  8. 11.2.3 China Poloxamer 338 Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Poloxamer 338 Market Size by Type
  2. 12.1.1 Asia Poloxamer 338 Revenue by Type (2021-2032)
  3. 12.1.2 Asia Poloxamer 338 Sales by Type (2021-2032)
  4. 12.1.3 Asia Poloxamer 338 Price by Type (2021-2032)
  5. 12.2 Asia Poloxamer 338 Market Size by Application
  6. 12.2.1 Asia Poloxamer 338 Revenue by Application (2021-2032)
  7. 12.2.2 Asia Poloxamer 338 Sales by Application (2021-2032)
  8. 12.2.3 Asia Poloxamer 338 Price by Application (2021-2032)
  9. 12.3 Asia Poloxamer 338 Market Size by Country
  10. 12.3.1 Asia Poloxamer 338 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Poloxamer 338 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Poloxamer 338 Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Poloxamer 338 Market Size by Type
  2. 13.1.1 SAMEA Poloxamer 338 Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Poloxamer 338 Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Poloxamer 338 Price by Type (2021-2032)
  5. 13.2 SAMEA Poloxamer 338 Market Size by Application
  6. 13.2.1 SAMEA Poloxamer 338 Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Poloxamer 338 Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Poloxamer 338 Price by Application (2021-2032)
  9. 13.3 SAMEA Poloxamer 338 Market Size by Country
  10. 13.3.1 SAMEA Poloxamer 338 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Poloxamer 338 Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Poloxamer 338 Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Poloxamer 338 Value Chain Analysis
  2. 14.1.1 Poloxamer 338 Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Poloxamer 338 Production Mode & Process
  6. 14.2 Poloxamer 338 Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Poloxamer 338 Distributors
  9. 14.2.3 Poloxamer 338 Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst